Wenwen Duan

机构：ShanghaiTech University, US Biologic (United States), Chengdu University of Traditional Chinese Medicine · ORCID：0000-0003-3280-4620

发表论文 15 篇 · 总被引 230 次 · h-index 10

代表论文

• Serotonin 2A Receptor (5-HT 2A R) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants (2023 · Chemical Reviews · 被引 65)
• Tumor Immunotherapy Using A2A Adenosine Receptor Antagonists (2020 · Pharmaceuticals · 被引 34)
• Design and Synthesis of Triazole-Containing HDAC Inhibitors That Induce Antitumor Effects and Immune Response (2023 · Journal of Medicinal Chemistry · 被引 27)
• Design, synthesis and biological evaluation of novel osimertinib derivatives as reversible EGFR kinase inhibitors (2022 · European Journal of Medicinal Chemistry · 被引 23)
• Design, synthesis and biological evaluation of novel N-(3-amino-4-methoxyphenyl)acrylamide derivatives as selective EGFRL858R/T790M kinase inhibitors (2021 · Bioorganic Chemistry · 被引 15)
• Dual-acting antitumor agents targeting the A2A adenosine receptor and histone deacetylases: Design and synthesis of 4-(furan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-amine derivatives (2022 · European Journal of Medicinal Chemistry · 被引 13)